109 related articles for article (PubMed ID: 19339478)
1. Proteasome inhibitors promote the sequestration of PrPSc into aggresomes within the cytosol of prion-infected CAD neuronal cells.
Dron M; Dandoy-Dron F; Farooq Salamat MK; Laude H
J Gen Virol; 2009 Aug; 90(Pt 8):2050-2060. PubMed ID: 19339478
[TBL] [Abstract][Full Text] [Related]
2. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
[TBL] [Abstract][Full Text] [Related]
3. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis.
Kristiansen M; Messenger MJ; Klöhn PC; Brandner S; Wadsworth JD; Collinge J; Tabrizi SJ
J Biol Chem; 2005 Nov; 280(46):38851-61. PubMed ID: 16157591
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations.
Fioriti L; Dossena S; Stewart LR; Stewart RS; Harris DA; Forloni G; Chiesa R
J Biol Chem; 2005 Mar; 280(12):11320-8. PubMed ID: 15632159
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-specific protease 14 modulates degradation of cellular prion protein.
Homma T; Ishibashi D; Nakagaki T; Fuse T; Mori T; Satoh K; Atarashi R; Nishida N
Sci Rep; 2015 Jun; 5():11028. PubMed ID: 26061634
[TBL] [Abstract][Full Text] [Related]
6. Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.
Lin Z; Zhao D; Yang L
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):477-84. PubMed ID: 23449072
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons.
Roucou X; Guo Q; Zhang Y; Goodyer CG; LeBlanc AC
J Biol Chem; 2003 Oct; 278(42):40877-81. PubMed ID: 12917444
[TBL] [Abstract][Full Text] [Related]
8. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.
Mishra RS; Bose S; Gu Y; Li R; Singh N
J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162
[TBL] [Abstract][Full Text] [Related]
9. Calpain and other cytosolic proteases can contribute to the degradation of retro-translocated prion protein in the cytosol.
Wang X; Wang F; Sy MS; Ma J
J Biol Chem; 2005 Jan; 280(1):317-25. PubMed ID: 15525638
[TBL] [Abstract][Full Text] [Related]
10. Novel amplification mechanism of prions through disrupting sortilin-mediated trafficking.
Sakaguchi S; Uchiyama K
Prion; 2017 Nov; 11(6):398-404. PubMed ID: 29099278
[TBL] [Abstract][Full Text] [Related]
11. Proteasomal Inhibition Redirects the PrP-Like Shadoo Protein to the Nucleus.
Kang SG; Mays CE; Daude N; Yang J; Kar S; Westaway D
Mol Neurobiol; 2019 Nov; 56(11):7888-7904. PubMed ID: 31129810
[TBL] [Abstract][Full Text] [Related]
12. Prion formation correlates with activation of translation-regulating protein 4E-BP and neuronal transcription factor Elk1.
Allard EK; Grujic M; Fisone G; Kristensson K
Neurobiol Dis; 2013 Oct; 58():116-22. PubMed ID: 23742760
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.
Ma J; Wollmann R; Lindquist S
Science; 2002 Nov; 298(5599):1781-5. PubMed ID: 12386337
[TBL] [Abstract][Full Text] [Related]
14. Flow Cytometric Detection of PrP
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
[TBL] [Abstract][Full Text] [Related]
15. Characterization of intracellular localization of PrP(Sc) in prion-infected cells using a mAb that recognizes the region consisting of aa 119-127 of mouse PrP.
Yamasaki T; Suzuki A; Shimizu T; Watarai M; Hasebe R; Horiuchi M
J Gen Virol; 2012 Mar; 93(Pt 3):668-680. PubMed ID: 22090211
[TBL] [Abstract][Full Text] [Related]
16. Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein.
Zanusso G; Petersen RB; Jin T; Jing Y; Kanoush R; Ferrari S; Gambetti P; Singh N
J Biol Chem; 1999 Aug; 274(33):23396-404. PubMed ID: 10438517
[TBL] [Abstract][Full Text] [Related]
17. Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin.
Mangé A; Crozet C; Lehmann S; Béranger F
J Cell Sci; 2004 May; 117(Pt 11):2411-6. PubMed ID: 15126640
[TBL] [Abstract][Full Text] [Related]
18. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
19. Cytosolic prion protein toxicity is independent of cellular prion protein expression and prion propagation.
Norstrom EM; Ciaccio MF; Rassbach B; Wollmann R; Mastrianni JA
J Virol; 2007 Mar; 81(6):2831-7. PubMed ID: 17182694
[TBL] [Abstract][Full Text] [Related]
20. Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death.
Cronier S; Carimalo J; Schaeffer B; Jaumain E; Béringue V; Miquel MC; Laude H; Peyrin JM
FASEB J; 2012 Sep; 26(9):3854-61. PubMed ID: 22661006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]